Cargando…
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Alcohol use disorder (AUD) is a highly prevalent but severely under-treated disorder, with only three widely-approved pharmacotherapies. Given that AUD is a very heterogeneous disorder, it is unlikely that one single medication will be effective for all individuals with an AUD. As such, there is a n...
Autores principales: | Burnette, Elizabeth M., Nieto, Steven J., Grodin, Erica N., Meredith, Lindsay R., Hurley, Brian, Miotto, Karen, Gillis, Artha J., Ray, Lara A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888464/ https://www.ncbi.nlm.nih.gov/pubmed/35133639 http://dx.doi.org/10.1007/s40265-021-01670-3 |
Ejemplares similares
-
Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial
por: Grodin, Erica N., et al.
Publicado: (2021) -
Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial
por: Burnette, Elizabeth M., et al.
Publicado: (2020) -
Translational opportunities in animal and human models to study alcohol use disorder
por: Nieto, Steven J., et al.
Publicado: (2021) -
Are medication effects on subjective response to alcohol and cue-induced craving associated? A meta regression study
por: Ray, Lara A., et al.
Publicado: (2023) -
A novel human laboratory model for screening medications for alcohol use disorder
por: Ho, Diana, et al.
Publicado: (2020)